Schedule 13G ownership disclosure

MOONLAKE IMMUNOTHERAPEUTICS

Class A Ordinary Shares · CUSIP: 61559X104

Event date: 2025-09-30

Filing-level shares
1,994,173
Percent of class
3.14%
  • Chen Bihua

    Shares: 1,994,173 · Class: 3.14%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-25-003714
Form type
SCHEDULE 13G/A
Filer
Chen Bihua
CIK
CIK 1599214
Filed
Oct 01, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub